October 25, 2018 A regimen showed favorable minimal residual disease negativity in patients with high-risk CLL, allowing many to pursue transplantation. A phase 2 clinical trial showed that ofatumumab with methylprednisolone followed by ofatumumab with…
Radiotherapy Did Not Improve Survival in All Patients…
October 29, 2018 Radiotherapy may improve survival among men with low metastatic burden. Adding radiotherapy to standard-of-care androgen deprivation therapy (ADT) did not improve survival in men with newly diagnosed metastatic prostate cancer, according to…